Cargando…
Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer()
BACKGROUND: To date, it remains unclear which patients with breast cancer (BC) benefit from post-mastectomy radiotherapy (PMRT). Cheng et al. developed and validated a scoring system based on 4 prognostic factors for locoregional recurrence (LRR) to identify patients in need for PMRT. These factors...
Autores principales: | Van der Vorst, Aline, Kindts, Isabelle, Laenen, Annouschka, Neven, Patrick, Janssen, Hilde, Weltens, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059150/ https://www.ncbi.nlm.nih.gov/pubmed/35468477 http://dx.doi.org/10.1016/j.breast.2022.04.007 |
Ejemplares similares
-
Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010) -
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020) -
Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy
por: Wen, Ge, et al.
Publicado: (2016) -
Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
por: Chang, Jee Suk, et al.
Publicado: (2015) -
Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)